NIH-funded research NIH-funded research

New therapies for essential tremor from cannabidiol mechanisms

Official title: New Therapies for Essential Tremor from Cannabidiols Mechanisms

Funded at VA Greater Los Angeles Healthcare System · NIH-11517167 · Data updated 2026-11-12

A patient-facing overview of how cannabis-based medicines might help tremor by targeting specific brain receptors, aiming to find better and better tolerated treatments for essential tremor.

More Essential Tremor research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Greater Los Angeles Healthcare System
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startApril 1, 2022
Project endMarch 31, 2027
Funding year2026
NIH project number5I01BX005887-05
Project IDNIH-11517167 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with essential tremor who may benefit from novel pharmacologic strategies targeting the shown receptors.

Less likely to help

Patients whose tremor does not respond to receptor-targeted approaches or who cannot tolerate cannabidiol-related therapies may see little benefit.

What this research studies

This grant explores how cannabidiol may reduce tremor by interacting with brain receptors, using animal models to uncover the underlying mechanisms. Researchers test how cannabidiol and receptor blockers change tremor in a harmaline-induced mouse model to map the pathways involved. The work focuses on translating these findings toward safer, more effective medicines for people living with essential tremor. The project builds on prior observations that cannabidiol can dampen tremor and seeks to clarify which receptors drive this effect. If successful, the results could guide new treatment approaches that improve quality of life for patients with tremor.

Why it matters

Potential benefit: If successful, this research could lead to new, better-tolerated medicines for essential tremor that specifically target the identified receptors.

How similar studies have gone: Prior work shows cannabidiol can suppress tremor in animal models and some clinical contexts, supporting further mechanism-focused research.

Where this research is happening

  • VA Greater Los Angeles Healthcare System
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Handforth, Charles Adrian — VA Greater Los Angeles Healthcare System
  • Study coordinator: Handforth, Charles Adrian

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.